Treatment Practice Patterns, Healthcare Resource Utilization (HRU), and Costs in Newly Diagnosed Patients with Therapy-Related Acute Myeloid Leukemia (TAML) or AML with Myelodysplasia-Related Changes (AML-MRC) in a United States (US) Commercially Insured Population
2018 ◽
Vol 21
(11)
◽
pp. 1119-1130
◽
2020 ◽
Vol 20
◽
pp. S177-S178
2013 ◽
Vol 11
(3)
◽
pp. 275-286
◽
2018 ◽
Vol 21
(6)
◽
pp. 556-563
◽